ArticleInflammopharmacology2023

A need for clinical trial: re-purposing the Monoamine Oxidase Inhibitors (MAO-I) for rheumatoid arthritis (RA).

Asis BalaPubMed ↗Publisher ↗

No numbers read from the abstract.